Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Bitcoin metric repeats bull move that saw up to 1,900% BTC price gains

Bitcoin metric repeats bull move that saw up to 1,900% BTC price gains

CointelegraphCointelegraph2024/03/01 15:10
By:William Suberg

Bitcoin ( BTC ) now has a shot at hitting $180,000, if a new bull signal repeats historical gains.

In a post on X (formerly Twitter) on Mar. 1, Caleb Franzen, founder of Cubic Analytics, suggested that BTC price returns could hit 260% from current levels this cycle.

Analyst eyes ultra rare Williams%R Oscillator signal

Bitcoin has added more than 43% in February alone, but a long-term BTC price metric is already calling for much higher levels.

Analyzing the Williams%R Oscillator on 3-year timeframes, Franzen revealed a rare bull signal flashing for only the fourth time ever.

“Bitcoin just completed the highest monthly close since Oct.'21, but it gets even better more bullish... The 36-month Williams%R Oscillator just closed above the overbought level for the 4th time in history,” he summarized.

The Williams%R Oscillator is used to gauge the strength of BTC price trends. As Cointelegraph reported, Franzen showed that the tool was essential in charting the start of Bitcoin’s recovery from the 2022 bear market lows.

While it was 12-month timeframes in play then, now, an even rarer occurrence is back — the 36-month Williams%R Oscillator is headed into “overbought” territory above -20.

“I say it all the time I'll continue to repeat it: overbought signals are incredibly bullish and should be viewed as momentum signals, not signals to fade,” Franzen continued.

Prior signals appeared in 2013, 2016 and 2020 — all years marking the early innings of a Bitcoin bull market.

While the returns have decreased each cycle — from 1,900% in 2013 to 260% in 2020 — even matching the latter would produce a $180,000 BTC price.

Franzen nonetheless acknowledged that even these unusual events should not be treated as a guarantee of future performance.

“The same analysis that I shared for the 12M and 24M Williams%R signals have worked perfectly; however, this study guarantees nothing. It simply tells us how market participants have behaved in the past when investor behavior was similar from a statistical perspective,” he explained.

“This study is unequivocally bullish, but we should view it simply as improving bullish probabilities rather than being outright bullish from a binary perspective.”
Bitcoin metric repeats bull move that saw up to 1,900% BTC price gains image 0
BTC/USD chart with 36-month Williams%R Oscillator. Source: Caleb Franzen/X

RSI extends bullish trend to monthly timeframes

Another indicator that tends to spend the steepest parts of bull markets at “overbought” levels is the Relative Strength Index (RSI).

Bitcoin metric repeats bull move that saw up to 1,900% BTC price gains image 1
BTC/USD 1-week chart with RSI. Source: TradingView

On daily timeframes, this is firmly overbought, briefly passing 80/100 on Feb. 28, data from Cointelegraph Markets Pro and TradingView confirms.

In late December, daily RSI executed a form of reset , which preceded Bitcoin’s initial push higher into the launch of the spot Bitcoin exchange-traded funds, or ETFs, in the United States.

What's more, monthly timeframes look even more optimistic with the RSI only now entering the “overbought” zone.

Bitcoin metric repeats bull move that saw up to 1,900% BTC price gains image 2
BTC/USD 1-month chart with RSI. Source: TradingView

 

This article does not contain investment advice or recommendations. Every investment and trading move involves risk, and readers should conduct their own research when making a decision.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Wall Street Stands Guard as Bessent Strikes Again: Aftereffects of August's "Treasury Turnaround" Persist, November Refinancing Notice Could Be the Next Flashpoint

As the US Treasury prepares to update its debt management plan in November, key clues may emerge on Friday.

智通财经•2026/10/16 01:06

"Coca-Cola belief" never goes out of style! KFC in America says goodbye to Pepsi and embraces Coca-Cola (KO.US); Buffett-style "boring investment" returns to the spotlight

KFC has chosen Coca-Cola as its soda supplier in the United States, abandoning its long-term partner Pepsi. As of the close of the U.S. stock market on Thursday, Coca-Cola's (KO.US) stock price reached a record high, defying the ongoing declines in global tech stocks, especially in the semiconductor and broad AI computing sectors.

智通财经•2026/10/16 01:06

AI financing concerns weigh heavily on chip stocks, global tech sector has lost over $1 trillion this week

Multiple pressures, including rising expectations of a Federal Reserve rate hike and increasing AI financing costs, have led to a massive sell-off in global tech stocks this week. The combined market value of the world's top 20 AI and semiconductor stocks has evaporated by more than $1 trillion, and the semiconductor ETF (SOXX) has recorded its longest losing streak in 11 years. On Thursday, SK Hynix continued to plunge by over 10% in a single day, while Nvidia, Samsung, and SoftBank were not spared.

华尔街见闻•2026/10/16 00:51

Safe Haven Amid AI Crash! Major Pharmaceutical Stocks Approach Historic Highs

Amid concerns over AI capital expenditures, funds are seeking a "certainty premium." State Street Healthcare ETF reached a record high. Eli Lilly and AbbVie are both approaching their historical highest closing prices, while Gilead and Amgen have surged 7.7% and 7.2% respectively over the past five days. Eli Lilly continues to bet on the future through its GLP-1 dominance and 40 M&A deals totaling $20 billion. AbbVie's core drug Skyrizi has shown positive data for its new subcutaneous formulation, which is expected to extend its patent and drive additional sales.

华尔街见闻•2026/10/16 00:37
Safe Haven Amid AI Crash! Major Pharmaceutical Stocks Approach Historic Highs